Category | Type of influenza vaccine |
Age | |
|
|
|
|
|
|
Chronic medical disorders | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other conditions | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IIV: inactivated influenza vaccine; LAIV: live attenuated influenza vaccine; BMI: body mass index; CSF: cerebrospinal fluid.
* LAIV may be administered to individuals who are healthy, nonpregnant, and 2 through 49 years of age.
¶ Contraindication to LAIV.
Δ Precaution for LAIV.
◊ Refer to UpToDate content on obesity in children for details.
§ Precaution for IIV.
¥ It is not known whether Guillain-Barré syndrome increases the risk of Guillain-Barré syndrome in children who developed Guillain-Barré syndrome within 6 weeks after a dose of influenza vaccine. The theoretic risk should be balanced against the potential morbidity and mortality of influenza infection.
‡ Contraindication for IIV.
† Although the prescribing information for LAIV includes severe allergic reaction to egg as a contraindication, the Advisory Committee on Immunization Practices and the American Academy of Pediatrics recommend any licensed vaccine that is appropriate for age and health status for individuals with egg allergy of any severity.Do you want to add Medilib to your home screen?